Health Catalyst Inc [HCAT] stock is trading at $4.18, up 5.29%. An important factor to consider is whether the stock is rising or falling in short-term value. The HCAT shares have gain 4.76% over the last week, with a monthly amount glided 9.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on April 09, 2025, when Evercore ISI downgraded its rating to a In-line. Previously, KeyBanc Capital Markets upgraded its rating to Overweight on January 08, 2025, and kept the price target unchanged to $9. On April 10, 2024, downgrade downgraded it’s rating to Sector Weight. Evercore ISI upgraded its rating to a Outperform but stick to its price target of $11 on January 03, 2024. Barclays initiated its recommendation with a Overweight and recommended $14 as its price target on January 03, 2024. JP Morgan upgraded its rating to Overweight for this stock on December 13, 2023, and downed its price target to $11. In a note dated November 13, 2023, Piper Sandler upgraded an Overweight rating on this stock and revised its target price from $12 to $11.
Health Catalyst Inc [HCAT] stock has fluctuated between $3.56 and $9.24 over the past year. Currently, Wall Street analysts expect the stock to reach $5.67 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $4.18 at the most recent close of the market. An investor can expect a potential return of 35.65% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
Health Catalyst Inc [NASDAQ:HCAT] reported sales of 311.27M for the trailing twelve months, which represents a growth of 6.28%. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.23%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.19 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.88 points at the first support level, and at 3.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.77, and for the 2nd resistance point, it is at 5.36.
Ratios To Look Out For
For context, Health Catalyst Inc’s Current Ratio is 1.24. On the other hand, the Quick Ratio is 1.42, and the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 0.93, the price to book ratio is 0.77.
Transactions by insiders
Recent insider trading involved LeSueur Daniel, Chief Operating Officer, that happened on May 05 ’25 when 5209.0 shares were sold. Chief Operating Officer, LeSueur Daniel completed a deal on Apr 03 ’25 to sell 5209.0 shares. Meanwhile, Officer DANIEL LESUEUR bought 10418.0 shares on Apr 03 ’25.
